Advertisement
Screener

Alkermes plc. (ALKS) Disposal Group, Including Discontinued Operation, Operating Income (Loss)

2.3 / 5 stars · 41/89 Roast Me

Alkermes plc. Disposal Group, Including Discontinued Operation, Operating Income (Loss)

Alkermes plc. (ALKS) reported Disposal Group, Including Discontinued Operation, Operating Income (Loss) of -$5.79 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss · last filed 2026-02-25

  • Alkermes plc. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2024-12-31 was $1.12M.
  • Alkermes plc. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2024-09-30 was -$481.00K.
  • Alkermes plc. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2024-06-30 was -$3.91M.
  • Alkermes plc. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2024-03-31 was -$2.52M.
  • Alkermes plc. disposal group, including discontinued operation, operating income (loss) for fiscal 2024 was -$5.79M.
  • Alkermes plc. disposal group, including discontinued operation, operating income (loss) for fiscal 2023 was -$164.80M.
  • Alkermes plc. disposal group, including discontinued operation, operating income (loss) for fiscal 2022 was -$136.18M.
  • Alkermes plc. disposal group, including discontinued operation, operating income (loss) for fiscal 2021 was -$127.03M.
Period endDisposal Group, Including Discontinued Operation, Operating Income (Loss) 3 monthDisposal Group, Including Discontinued Operation, Operating Income (Loss) 6 monthDisposal Group, Including Discontinued Operation, Operating Income (Loss) 9 monthDisposal Group, Including Discontinued Operation, Operating Income (Loss) 12 month
2024-12-31$1.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$639.00K
derived: sum of 2 quarters · filed 2026-02-25
-$3.27M
derived: sum of 3 quarters · filed 2026-02-25
-$5.79M
10-K · filed 2026-02-25
2024-09-30-$481.00K
10-Q · filed 2025-10-28
-$4.39M
derived: sum of 2 quarters · filed 2025-10-28
-$6.91M
10-Q · filed 2025-10-28
-$47.77M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30-$3.91M
10-Q · filed 2025-07-29
-$6.43M
10-Q · filed 2025-07-29
-$47.29M
derived: sum of 3 quarters · filed 2026-02-25
-$92.63M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31-$2.52M
10-Q · filed 2025-05-01
-$43.38M
derived: sum of 2 quarters · filed 2026-02-25
-$88.72M
derived: sum of 3 quarters · filed 2026-02-25
-$130.80M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31-$40.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
-$86.20M
derived: sum of 2 quarters · filed 2026-02-25
-$128.28M
derived: sum of 3 quarters · filed 2026-02-25
-$164.80M
10-K · filed 2026-02-25
2023-09-30-$45.35M
10-Q · filed 2024-10-24
-$87.42M
derived: sum of 2 quarters · filed 2024-10-24
-$123.94M
10-Q · filed 2024-10-24
2023-06-30-$42.08M
10-Q · filed 2024-07-24
-$78.60M
10-Q · filed 2024-07-24
2023-03-31-$36.52M
10-Q · filed 2024-05-01
2022-12-31-$136.18M
10-K · filed 2025-02-12
2021-12-31-$127.03M
10-K · filed 2024-02-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76